On July 8, 2025, Repligen (RGEN, Financial), a life sciences company, saw its price target adjusted by Evercore ISI Group. The analyst responsible for this update, Daniel Markowitz, decided to lower the price target from the prior figure of $140.00 USD to a new target of $130.00 USD. This adjustment represents a -7.14% change in the price target.
Despite the change in the price target, the rating for Repligen (RGEN, Financial) remained unchanged. Evercore ISI Group continues to maintain an 'In-Line' rating for the stock, consistent with their previous assessment.
Investors in Repligen (RGEN, Financial) may take note of this adjustment as part of their broader evaluation of the company's market position and anticipated performance. The decision to maintain the 'In-Line' rating suggests that the analyst sees the stock's potential performance as consistent with overall market expectations.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 16 analysts, the average target price for Repligen Corp (RGEN, Financial) is $181.63 with a high estimate of $220.00 and a low estimate of $140.00. The average target implies an upside of 45.97% from the current price of $124.43. More detailed estimate data can be found on the Repligen Corp (RGEN) Forecast page.
Based on the consensus recommendation from 20 brokerage firms, Repligen Corp's (RGEN, Financial) average brokerage recommendation is currently 2.1, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Repligen Corp (RGEN, Financial) in one year is $178.65, suggesting a upside of 43.57% from the current price of $124.43. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Repligen Corp (RGEN) Summary page.
